Ahmad Mustafa Shiri
Overview
Explore the profile of Ahmad Mustafa Shiri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shiri A, Fard-Aghaie M, Bedke T, Papazoglou E, Sabihi M, Zazara D, et al.
Sci Rep
. 2024 Dec;
14(1):30483.
PMID: 39681594
The lung is one of the most frequently metastasized organs from various cancer entities, especially colorectal cancer (CRC). The occurrence of lung metastasis correlates with worse prognosis in CRC patients....
2.
Zhang T, Seeger P, Simsek Y, Sabihi M, Lucke J, Zazara D, et al.
Heliyon
. 2024 Mar;
10(6):e27578.
PMID: 38533053
Background: Insufficient remnant liver volume (RLV) after the resection of hepatic malignancy could lead to liver failure and mortality. Portal vein ligation (PVL) prior to hepatectomy is subsequently introduced to...
3.
Shiri A, Zhang T, Bedke T, Zazara D, Zhao L, Lucke J, et al.
J Hepatol
. 2023 Dec;
80(4):634-644.
PMID: 38160941
Background & Aims: The liver is one of the organs most commonly affected by metastasis. The presence of liver metastases has been reported to be responsible for an immunosuppressive microenvironment...
4.
Zhang T, Wahib R, Zazara D, Lucke J, Shiri A, Kempski J, et al.
Oncoimmunology
. 2023 Oct;
12(1):2269634.
PMID: 37876835
Metastasis is a cancer-related systemic disease and is responsible for the greatest mortality rate among cancer patients. Interestingly, the interaction between the immune system and cancer cells seems to play...
5.
Giannou A, Kempski J, Zhang T, Lucke J, Shiri A, Zazara D, et al.
Front Oncol
. 2023 Jun;
13:1170502.
PMID: 37324022
Background: The immune system plays a pivotal role in cancer progression. Interleukin 22 binding protein (IL-22BP), a natural antagonist of the cytokine interleukin 22 (IL-22) has been shown to control...
6.
Kotsiliti E, Leone V, Schuehle S, Govaere O, Li H, Wolf M, et al.
J Hepatol
. 2023 May;
79(2):296-313.
PMID: 37224925
Background & Aims: The progression of non-alcoholic steatohepatitis (NASH) to fibrosis and hepatocellular carcinoma (HCC) is aggravated by auto-aggressive T cells. The gut-liver axis contributes to NASH, but the mechanisms...
7.
Giannou A, Kempski J, Shiri A, Lucke J, Zhang T, Zhao L, et al.
Immunity
. 2023 Jan;
56(1):125-142.e12.
PMID: 36630911
During metastasis, cancer cells invade, intravasate, enter the circulation, extravasate, and colonize target organs. Here, we examined the role of interleukin (IL)-22 in metastasis. Immune cell-derived IL-22 acts on epithelial...
8.
Giannou A, Lucke J, Kleinschmidt D, Shiri A, Steglich B, Nawrocki M, et al.
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551508
Hepatocellular carcinoma (HCC) ranks among the five most common cancer entities worldwide and leads to hundred-thousands of deaths every year. Despite some groundbreaking therapeutical revelations during the last years, the...
9.
Zhao L, Giannou A, Xu Y, Shiri A, Liebold I, Steglich B, et al.
Sci Adv
. 2021 Aug;
7(33).
PMID: 34389533
Malignant pleural effusion (MPE) results from the capacity of several human cancers to metastasize to the pleural cavity. No effective treatments are currently available, reflecting our insufficient understanding of the...
10.
Lucke J, Sabihi M, Zhang T, Bauditz L, Shiri A, Giannou A, et al.
Semin Immunopathol
. 2021 Apr;
43(4):591-607.
PMID: 33851257
The human liver fulfills several vital tasks daily and possesses an impressive ability to self-regenerate. However, the capacity of this self-healing process can be exhausted by a variety of different...